
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Intrinsic Value
The intrinsic value of one
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
stock under the Base Case scenario is
37.2
CNY.
Compared to the current market price of 31.44 CNY,
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
is
Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Balance Sheet Decomposition
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Current Assets | 7.1B |
Cash & Short-Term Investments | 1.5B |
Receivables | 2.9B |
Other Current Assets | 2.8B |
Non-Current Assets | 3.8B |
Long-Term Investments | 942.1m |
PP&E | 1.5B |
Intangibles | 371m |
Other Non-Current Assets | 1.1B |
Free Cash Flow Analysis
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Revenue
|
8B
CNY
|
Cost of Revenue
|
-4.4B
CNY
|
Gross Profit
|
3.7B
CNY
|
Operating Expenses
|
-2.9B
CNY
|
Operating Income
|
793.6m
CNY
|
Other Expenses
|
138.7m
CNY
|
Net Income
|
932.4m
CNY
|
Profitability Score
Profitability Due Diligence
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Score
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Score
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
According to Wall Street analysts, the average 1-year price target for
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
is 46.72 CNY
with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.
Dividends
Current shareholder yield for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
stock under the Base Case scenario is
37.2
CNY.
Compared to the current market price of 31.44 CNY,
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
is
Undervalued by 15%.